Modelling Survival in the Presence of Different Mechanisms of Action- Ipilimumab and Vemurafenib in Advanced Melanoma
Nov 1, 2014, 00:00 AM
10.1016/j.jval.2014.08.1832
https://www.valueinhealthjournal.com/article/S1098-3015(14)03762-0/fulltext
Section Title :
Research on Methods Studies
Section Order :
1307
First Page :
A557
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)03762-0&doi=10.1016/j.jval.2014.08.1832